Caris Life Sciences (CAI) Metrics: History & Chart

Caris Life Sciences, Inc.(CAI)

Biotechnology · Irving, TX

$28.46-1.93 (-6.35%)

Delayed quote: Oct 6, 2026, 1:10 PM EDT

About Caris Life Sciences, Inc.

Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.

Irving, TX

1,846 employees

www.carislifesciences.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: David Dean Halbert

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-4.28%
30D Total Return	+21.22%
YTD Total Return	+12.64%
1Y Total Return	-4.37%
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+12.64%
2025	N/A
2024	N/A
2023	N/A
2022	N/A
2021	N/A

CAGR TTM	-4.35%
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	84.91
PE Ratio Avg TTM	73.85
PE Ratio Avg 3Y	73.85
Current VS TTM Avg	+14.98%
Current VS 3Y Avg	+14.98%
Current VS 5Y Avg	+14.98%

All Metrics

CAI Valuation Metrics

CAI Stock Price Metrics

CAI Dividend Metrics

CAI Growth Rate Metrics

CAI Discounted Cash Flow Metrics

CAI Returns By Period

CAI Yearly Returns

CAI Average Annual Returns By Period (CAGR)

CAI Revenue Metrics

CAI PE Ratio Metrics

CAI PS Ratio Metrics

CAI PB Ratio Metrics

CAI Price to Free Cash Flow Ratio Metrics

CAI Debt to Equity Ratio Metrics

CAI PEG Ratio Metrics

CAI FCF Yield

CAI Earnings Yield

CAI EBITDA Yield

CAI OCF Yield

CAI EV/EBIT Ratio Metrics

CAI EV/EBITDA Ratio Metrics

CAI EV/Assets Ratio Metrics

CAI EV/Sales Ratio Metrics

CAI Current Ratio Metrics

CAI Quick Ratio Metrics

CAI ROIC Metrics

CAI Return on Assets Metrics

CAI Return on Equity Metrics

CAI Net Profit Margin Metrics

CAI Gross Profit Margin Metrics

CAI Tax Rate Metrics

PS Ratio	8.69
PS Ratio Avg TTM	8.82
PS Ratio Avg 3Y	10.67
Current VS TTM Avg	-1.50%
Current VS 3Y Avg	-18.55%
Current VS 5Y Avg	-18.55%

PB Ratio	14.53
PB Ratio Avg TTM	12.38
PB Ratio Avg 3Y	13.49
Current VS TTM Avg	+17.33%
Current VS 3Y Avg	+7.74%
Current VS 5Y Avg	+7.74%

PFCF Ratio	58.69
PFCF Ratio Avg TTM	55.74
PFCF Ratio Avg 3Y	55.74
Current VS TTM Avg	+5.28%
Current VS 3Y Avg	+5.28%
Current VS 5Y Avg	+5.28%

Debt/Equity Ratio	0.76
Debt/Equity Ratio Avg TTM	0.79
Debt/Equity Ratio Avg 3Y	0.23
Current VS TTM Avg	-3.57%
Current VS 3Y Avg	+236.46%
Current VS 5Y Avg	+80.94%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	1.70%
FCF Yield Avg TTM	2.01%
FCF Yield Avg 3Y	2.01%
Current VS TTM Avg	-15.25%
Current VS 3Y Avg	-15.25%
Current VS 5Y Avg	-15.25%

Earnings Yield	1.18%
Earnings Yield Avg TTM	1.38%
Earnings Yield Avg 3Y	1.38%
Current VS TTM Avg	-14.33%
Current VS 3Y Avg	-14.33%
Current VS 5Y Avg	-14.33%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	54.54
Ev/Ebit Ratio Avg TTM	45.18
Ev/Ebit Ratio Avg 3Y	45.18
Current VS TTM Avg	+20.72%
Current VS 3Y Avg	+20.72%
Current VS 5Y Avg	+20.72%

Ev/Ebitda Ratio	48.03
Ev/Ebitda Ratio Avg TTM	37.76
Ev/Ebitda Ratio Avg 3Y	37.76
Current VS TTM Avg	+27.19%
Current VS 3Y Avg	+27.19%
Current VS 5Y Avg	+27.19%

Ev/Assets Ratio	6.80
Ev/Assets Ratio Avg TTM	5.77
Ev/Assets Ratio Avg 3Y	6.26
Current VS TTM Avg	+17.92%
Current VS 3Y Avg	+8.58%
Current VS 5Y Avg	+8.58%

Ev/Sales Ratio	8.45
Ev/Sales Ratio Avg TTM	8.37
Ev/Sales Ratio Avg 3Y	10.36
Current VS TTM Avg	+0.92%
Current VS 3Y Avg	-18.43%
Current VS 5Y Avg	-18.43%

Current Ratio	5.53
Current Ratio Avg TTM	7.92
Current Ratio Avg 3Y	4.19
Current VS TTM Avg	-30.22%
Current VS 3Y Avg	+31.72%
Current VS 5Y Avg	+53.79%

Quick Ratio	4.88
Quick Ratio Avg TTM	7.58
Quick Ratio Avg 3Y	3.98
Current VS TTM Avg	-35.67%
Current VS 3Y Avg	+22.54%
Current VS 5Y Avg	+42.86%

ROIC	14.76%
ROIC Avg 3Y	(11.79%)
ROIC Avg 5Y	(7.82%)
Current VS 3Y Avg	+225.19%
Current VS 5Y Avg	+288.80%
Current VS 10Y Avg	+226.24%

ROA	8.55%
ROA Avg TTM	0.43%
ROA Avg 3Y	(4.38%)
Current VS TTM Avg	+1898.70%
Current VS 3Y Avg	+295.25%
Current VS 5Y Avg	+1209.11%

ROE	17.77%
ROE Avg TTM	(17.80%)
ROE Avg 3Y	(17.80%)
Current VS TTM Avg	+199.83%
Current VS 3Y Avg	+199.83%
Current VS 5Y Avg	+314.59%

Net Profit Margin	10.62%
Net Profit Margin Avg TTM	(0.17%)
Net Profit Margin Avg 3Y	(38.46%)
Current VS TTM Avg	+6328.29%
Current VS 3Y Avg	+127.62%
Current VS 5Y Avg	+144.01%

Gross Profit Margin	69.66%
Gross Pft Margin Avg TTM	67.92%
Gross Pft Margin Avg 3Y	55.48%
Current VS TTM Avg	+2.56%
Current VS 3Y Avg	+25.55%
Current VS 5Y Avg	+17.99%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	5.42%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	-100.00%
Current VS 10Y Avg	-100.00%